Our meta-analysis indicated that MSC therapy was associated with an increase in serum IL-10 levels in MS models; however, this elevation did not reach statistical significance (SMD = 7.36, 95% CI: −0.58 to 15.29, I 2 = 99.73%, P = 0.07, Fig. 6 A) (Hao et al. 2016 , Li et al. 2019 , Yu et al. 2016 , Ryu et al. 2013 , Guo et al. 2013 , Nasri et al. 2018 ).
← all excerpts
Neuro-Behavioral Improvement and Mechanistic Pathways of Bone Marrow-Derived Mesenchymal Stem Cells and Exosomes in Experimental Multiple Sclerosis: A Systematic Review and Meta-analysis.
1
0.0700
0.0700